Life Sciences Tools and Services
Company Overview of Ajinomoto Althea, Inc.
Ajinomoto Althea, Inc. provides biopharmaceutical contract development and manufacturing services to biotechnology and pharmaceutical companies worldwide. It offers development services in the areas of process development, protein formulation technology, analytical development and validation, and regulatory support. The company also provides services related to drug substances, such as cGMP protein/plasmid DNA production, microbial cell banking, patented protein expression technology, analytics, and regulatory support. In addition, it offers drug product manufacturing services, including formulation, aseptic vial filling, aseptic pre-filled syringe filling, lyophilization, stability and rele...
11040 Roselle Street
San Diego, CA 92121
Founded in 1997
Key Executives for Ajinomoto Althea, Inc.
Chief Executive Officer and President
Chief Financial Officer and Senior Vice President
Senior Vice President of Operations
Vice President of Biologics
Compensation as of Fiscal Year 2015.
Ajinomoto Althea, Inc. Key Developments
Ajinomoto Althea, Inc. Expands Manufacturing Capabilities to Antibody Drug Conjugate Fill Finish and Bioconjugation
Oct 14 15
Ajinomoto Althea, Inc. announced it is expanding its existing biological drug product manufacturing operations to include highly active materials such as Antibody Drug Conjugates (ADCs). The new facility is located in close proximity to existing Althea operations in San Diego, CA.
Ajinomoto Althea, Inc. Presents at 7th annual Biotech Showcase Conference 2015, Jan-12-2015
Dec 24 14
Ajinomoto Althea, Inc. Presents at 7th annual Biotech Showcase Conference 2015, Jan-12-2015 . Venue: Parc 55 Wyndham San, Francisco - Union Square, San Francisco, CA 94102, United States.
Ajinomoto Althea Inc. Appoints J. David Enloe Jr. as President and Chief Executive Officer
Jan 6 14
Ajinomoto Althea Inc. announced the appointment of J. David Enloe Jr. as President and CEO. Mr. Enloe will be responsible for developing strategies to support the company's continued growth. Enloe brings over 20 years of executive management experience most of that in biotechnology, drug development, and GMP manufacturing management. Most recently, he served as the Head of the Viral Therapeutics Business Unit at Lonza AG. Mr. Enloe joined the team effective December 16, 2013. Dr. Hiroshi Shiragami and Dr. Magda Marquet will continue to serve Ajinomoto Althea Inc. as Co-Chairs of the board of directors.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|